ALS typically starts with weakness in a single hand, foot, or arm, or with subtle changes in speech or swallowing. The disease begins in one focal spot and spreads outward from there, which is why early symptoms are often mistaken for a pinched nerve, arthritis, or normal aging. The average time from first symptom to diagnosis is about 12 months, partly because the earliest signs are so easy to dismiss.
Where Symptoms First Appear
In 60 to 80% of people with ALS, the first noticeable problem is weakness in an arm or leg. This is called limb-onset ALS. You might notice that one hand has become clumsy, that you’re dropping things more often, or that your grip feels weaker. In the legs, it can show up as tripping, foot drop, or a feeling of heaviness or fatigue that doesn’t match your activity level. The weakness is almost always asymmetric, meaning it hits one side before the other, and it tends to start in the hand or foot rather than the shoulder or hip.
Because these symptoms look so much like common musculoskeletal problems, many people are initially evaluated for conditions like degenerative disc disease or carpal tunnel syndrome before ALS enters the picture.
A smaller group, roughly 20 to 25% of patients, first notice changes in speech or swallowing. This is called bulbar-onset ALS. Early signs include slurred or slow speech, a hoarse or nasal voice quality, and difficulty swallowing certain foods. Some people notice increased saliva or a feeling of food getting stuck in the throat. Coughing during meals, nasal regurgitation of liquids, and unexplained weight loss from eating less can all be early signals.
In rare cases, about 1 to 3% of patients, ALS first shows up as breathing difficulty. These people may not have shortness of breath at rest initially, but they notice unusual fatigue during physical activity, an inability to take deep breaths, or poor sleep quality. Evidence suggests that even in patients with no respiratory complaints, the breathing muscles can begin to weaken early, sometimes causing shallow breathing during sleep before any daytime symptoms appear.
How ALS Spreads Through the Body
One of the defining features of ALS is that it starts in one small area and radiates outward to neighboring regions in a predictable, contiguous pattern. A neurologist in the 1880s named William Gowers first described this clearly: weakness begins in one part of a limb, then spreads to other parts of the same limb, then typically appears in the corresponding limb on the opposite side, often in the same muscles where it originally started.
This happens because the disease process moves along the physical anatomy of motor neurons, both the upper motor neurons (which run from the brain down the spinal cord) and the lower motor neurons (which run from the spinal cord out to muscles). Each level spreads independently along its own pathway, and as they overlap over time, the pattern of weakness becomes more complex and widespread. What starts as a subtle problem in one hand can, over months, involve the entire arm, then the other arm, then eventually the legs and trunk. The spread isn’t random. It follows the wiring of the nervous system.
What Happens Inside the Nervous System
ALS destroys motor neurons, the nerve cells responsible for voluntary movement. Both the upper motor neurons in the brain and the lower motor neurons in the spinal cord and brainstem are affected, though not always at the same rate. When upper motor neurons are damaged, muscles become stiff and reflexes become exaggerated. When lower motor neurons die, muscles weaken, shrink, and twitch.
The biological trigger isn’t a single event. Current understanding points to a cascade involving abnormal protein buildup inside neurons, likely driven by problems with how cells process their genetic instructions. These misfolded proteins accumulate and become toxic. Alongside this, motor neurons become overstimulated by glutamate, a chemical messenger that normally helps neurons communicate but in excess essentially burns them out. Mitochondria, the energy-producing structures inside cells, stop functioning properly. Inflammation around the neurons accelerates damage. These processes feed on each other, creating a cycle that the body can’t reverse once it gains momentum.
Muscle Twitching: When to Worry
Muscle twitching (fasciculations) is one of the most anxiety-provoking symptoms people search for in connection with ALS, but context matters enormously. In ALS, fasciculations are widespread, persistent, and occur alongside progressive weakness. Ultrasound studies show that twitching in ALS patients tends to be diffuse across multiple body regions and concentrated in the muscles closer to the trunk, like the upper arms and thighs. In people without ALS, twitching is typically limited to one or two spots, intermittent, and concentrated in the calves or other distal muscles.
One particularly telling finding: fasciculations in the muscles under the chin and around the throat are highly specific to ALS and essentially absent in people with benign twitching or other nerve conditions. The key distinction is that benign fasciculations happen without weakness, without muscle wasting, and without progression. If your muscles are twitching but your strength is completely normal and stays normal over weeks and months, the twitching is overwhelmingly likely to be harmless.
Who Gets ALS and When
ALS is rare before age 40. The mean age of onset for sporadic ALS is 58 to 63 years, with peak incidence in people aged 70 to 79. Familial ALS, which runs in families, tends to appear somewhat earlier, between ages 40 and 60. Men are slightly more likely to develop ALS than women, with a male-to-female ratio of about 1.2 to 1.5.
About 90% of ALS cases are sporadic, meaning they occur in people with no family history of the disease. The remaining 10% are familial, linked to inherited genetic mutations. The most common genetic cause is a repeat expansion in a gene called C9orf72, responsible for 30 to 60% of familial cases and 5 to 10% of sporadic ones. Other genes involved include SOD1, TARDBP, and FUS, but even in sporadic ALS, the disease process appears to involve a combination of genetic susceptibility and environmental triggers that alter how genes are expressed rather than changing the genetic code itself.
Why Diagnosis Takes So Long
The median time from first symptoms to a confirmed ALS diagnosis is approximately 12 months, and this delay persists even in countries with advanced healthcare systems. Part of the problem is that no single blood test or scan can confirm ALS. Diagnosis still relies on clinical evaluation: a neurologist must find evidence of both upper and lower motor neuron damage, rule out other conditions that mimic ALS, and document that symptoms are progressing over time.
Electromyography (EMG), which measures electrical activity in muscles, plays a key supporting role. Newer diagnostic frameworks like the Gold Coast criteria have simplified the process into a straightforward yes-or-no determination rather than older systems that assigned levels of diagnostic certainty like “possible” or “probable.” This has helped catch more cases earlier, but the fundamental challenge remains. Early ALS can look like dozens of other conditions, and confirming it requires watching the pattern unfold.
For people in the early stages, this waiting period is one of the hardest parts. The disease often declares itself clearly only after it has spread beyond its starting point, which is precisely why understanding the focal onset and contiguous spread pattern matters. A neurologist tracking weakness that started in one hand and has moved to the forearm and then the upper arm over several months is seeing a signature pattern that points strongly toward ALS, even before every diagnostic box is checked.